Reveals no increased venous thromboembolism risk with contraceptive progestagens alone but a substantial association at higher doses, highlighting dose-dependent safety profiles.
Overall, there was a modest, non-significant, positive association between exposure to progestagens alone and venous thromboembolism (VTE). There was no effect with progestagens alone used for contraception, whereas there was a substantial association with the higher dose progestagens used for other reasons.
No takes yet. Share an insight, caveat, or question.
Vasilakis et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: